Cost-effectiveness of the implantable cardioverter defibrillator: A review of current evidence

Journal of Cardiovascular Electrophysiology

Volumn 14, Issue 9 SUPPL., 2003, Pages

  Lynd, Larry D ^a   O'Brien, Bernie J ^a,b  

^a CENTRE FOR EVALUATION OF MEDICINES   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Cost effectiveness; Economics; Evaluation; Implantable defibrillator

Indexed keywords

ANTIARRHYTHMIC AGENT;

CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DATA BASE; DEFIBRILLATOR; ECONOMIC ASPECT; HEALTH ECONOMICS; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL RESEARCH; MEDLINE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SUDDEN DEATH;

EID: 0141501298     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.14.s9.3.x     Document Type: Conference Paper

References (24)

1. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1567-1583.
2. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
3. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien BJ: Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302.
4. Moss AJ, Zareba W, Hall WJ: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
5. Ontario Guidelines for Economic Analysis of Pharmaceutical Products. Toronto, Canada: Ontario Ministry of Health and Long Term Care, 1994, Report No. 2227446.
6. Guidelines for Economic Evaluation of Pharmaceuticals: Canada. Second Edition. Ottawa, Canada: The Canadian Coordinating Office for Health Technology Assessment, 1997.
7. Guidance for Sponsors and Manufacturers: Technology Appraisals Process Series No. 5. London, UK: National Institute for Clinical Excellence, 2001, Report No. N0014.
8. International Academy of Cardiology, 2002. MADIT II findings support prophylactic use of ICDs. Accessed March 25, 2003 from www.cardiologyonline.com/journal_articles/Madit.htm
9. Owens DK, Sanders GD, Heidenreich PA, McDonald KM, Hlatky MA: Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. Am Heart J 2002;144:440-448.
10. Sheldon R, O'Brien BJ, Blackhouse G, Goeree R, Mitchell B, Klein G, Roberts RS, Gent M, Connolly SJ: Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: The Canadian implantable defibrillator study. Circulation 2001;104:1622-1626.
11. Wever EF, Hauer RN, van Capelle FL, Tijssen JG, Crijns HJ, Algra A, Wiesfeld AC, Bakker PF, Robles De Medina EO: Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in post-infarct sudden death survivors. Circulation 1995;91:2195-2203.
12. Mushlin AI, Hall WJ, Zwanziger J, Gajary E, Andrews M, Marron R, Zou KH, Moss AJ: The cost-effectiveness of automatic implantable cardiac defibrillators: Results from MADIT. Circulation 1998;97:2129-2135.
13. Larsen G, Hallstrom A, McAnulty J, Pinski S, Olarte A, Sullivan S, Brodsky M, Powell J, Marchant C, Jennings C, Akiyama T: Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis sub-study. Circulation. 2002;105:2049-2057.
14. O'Brien BJ, Connolly SJ, Goeree R, Blackhouse G, Willan A, Yee R, Roberts RS, Gent M: Cost-effectiveness of the implantable cardioverter-defibrillator: Results from the Canadian Implantable Defibrillator Study (CIDS). Circulation 2001;103:1416-1421.
15. Kuppermann M, Luce BR, McGovern B, Podrid PJ, Bigger JT Jr, Ruskin JN: An analysis of the cost effectiveness of the implantable defibrillator. Circulation 1990;81:91-100.
16. O'Brien BJ, Buxton MJ, Rushby JA: Cost effectiveness of the implantable cardioverter defibrillator: A preliminary analysis. Br Heart J 1992;68:241-245.
17. Larsen GC, Manolis AS, Sonnenberg FA, Beshansky JR, Estes NA, Pauker SG: Cost-effectiveness of the implantable cardioverter-defibrillator: Effect of improved battery life and comparison with amiodarone therapy. J Am Coll Cardiol 1992;19:1323-1334.
18. Kupersmith J, Hogan A, Guerrero P, Gardiner J, Mellits ED, Baumgardner R, Rovner D, Holmes-Rovner M, McLane A, Levine J: Evaluating and improving the cost-effectiveness of the implantable cardioverter-defibrillator. Am Heart J 1995;130(3 Pt 1):507-515.
19. Owens DK, Sanders GD, Harris RA, McDonald KM, Heidenreich PA, Dembitzer AD, Hlatky MA: Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med 1997;126:1-12.
20. Sanders GD, Hlatky MA, Every NR, McDonald KM, Heidenreich PA, Parsons LS, Owens DK: Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction. Ann Intern Med 2001;135:870-883.
21. Weiss JP, Saynina O, McDonald KM, McClellan MB, Hlatky MA: Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among Medicare beneficiaries. Am J Med 2002;112:519-527.
22. Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M: Identification of patients most likely to benefit from ICD therapy: The Canadian Implantable Defibrillator Study. Circulation 2000;101:1660-1664.
23. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, Newman D, Connolly S: Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002;144:282-289.
24. Hohnloser SH, Connolly SJ, Kuck KH, Dorian P, Fain E, Hampton JR, Hatala R, Pauly AC, Roberts RS, Themeles E, Gent M: The defibrillator in acute myocardial infarction trial (DINAMIT): Study protocol. Am Heart J 2000;140:735-739.